CVE-2022-4731
CVE-2022-4731 is a low-severity vulnerability in Myapnea with a CVSS 3.x base score of 2.4. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.
Key facts
- Severity: Low (CVSS 3.x base score 2.4)
- EPSS exploit prediction: 1% (40th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-79
- Affected product: Myapnea
- Published:
- Last modified:
Description
A vulnerability, which was classified as problematic, was found in myapnea up to 29.0.x. Affected is an unknown function of the component Title Handler. The manipulation leads to cross site scripting. It is possible to launch the attack remotely. Upgrading to version 29.1.0 is able to address this issue. The name of the patch is 99934258530d761bd5d09809bfa6c14b598f8d18. It is recommended to upgrade the affected component. VDB-216750 is the identifier assigned to this vulnerability.
Frequently asked questions
- What is CVE-2022-4731?
- A vulnerability, which was classified as problematic, was found in myapnea up to 29.0.x. Affected is an unknown function of the component Title Handler. The manipulation leads to cross site scripting. It is possible to launch the attack remotely. Upgrading to version 29.1.0 is able to address this issue. The name of the patch is 99934258530d761bd5d09809bfa6c14b598f8d18. It is recommended to upgrade the affected component. VDB-216750 is the identifier assigned to this vulnerability.
- How severe is CVE-2022-4731?
- CVE-2022-4731 has a CVSS 3.x base score of 2.4, rated low severity. It is exploitable over network with low attack complexity, requires high privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
- Is CVE-2022-4731 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (40th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2022-4731?
- CVE-2022-4731 affects Myapnea. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2022-4731?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2022-4731 published?
- CVE-2022-4731 was published on 2022-12-25 and last updated on 2026-06-17.
References
- https://github.com/myapnea/myapnea.org/commit/99934258530d761bd5d09809bfa6c14b598f8d18
- https://github.com/myapnea/myapnea.org/releases/tag/v29.1.0
- https://vuldb.com/?ctiid.216750
- https://vuldb.com/?id.216750
Affected products (1)
- cpe:2.3:a:myapnea:myapnea:*:*:*:*:*:*:*:*
Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities
- CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
- CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
- CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
- CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
- CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
- CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…
Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →